Jiangsu Zhongjin Matai Medicinal Packaging Co
Jiangsu Zhongjin Matai Medicinal Packaging Co., a leading name in the pharmaceutical packaging industry, is headquartered in Jiangsu, China. Established in 2003, the company has made significant strides in providing innovative packaging solutions tailored for the medicinal sector. With a strong operational presence across various regions in China, Jiangsu Zhongjin Matai focuses on producing high-quality, compliant packaging materials that ensure the safety and efficacy of pharmaceutical products. The company’s core offerings include blister packs, bottles, and other specialised packaging solutions, distinguished by their durability and regulatory compliance. Jiangsu Zhongjin Matai has earned a reputable market position, recognised for its commitment to quality and customer satisfaction. With a focus on continuous improvement and technological advancement, the company remains a trusted partner for pharmaceutical manufacturers seeking reliable packaging solutions.
DitchCarbon Score
How does Jiangsu Zhongjin Matai Medicinal Packaging Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jiangsu Zhongjin Matai Medicinal Packaging Co's score of 10 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jiangsu Zhongjin Matai Medicinal Packaging Co's reported carbon emissions
Jiangsu Zhongjin Matai Medicinal Packaging Co., Ltd, headquartered in China, currently does not report any specific carbon emissions data. However, the company has made significant climate commitments aimed at reducing its greenhouse gas (GHG) emissions. The company has set ambitious targets to reduce its absolute Scope 1 and Scope 2 GHG emissions by 42% by the year 2030, using 2022 as the baseline year. Additionally, Jiangsu Zhongjin Matai aims to decrease its Scope 3 emissions from purchased goods and services by approximately 51.6% per ton of product produced within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are consistent with efforts to limit global warming to 1.5°C. Furthermore, Jiangsu Zhongjin Matai has committed to achieving net-zero emissions across all scopes by 2050, demonstrating a long-term commitment to sustainability and climate action. These initiatives reflect the company's proactive approach to addressing climate change within the healthcare equipment and supplies sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jiangsu Zhongjin Matai Medicinal Packaging Co is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
